J&J Unit To Shell Out $85M Over Bad Natrecor Labeling

Law360, New York (September 14, 2011, 7:39 PM EDT) -- Johnson & Johnson subsidiary Scios Inc. agreed Wednesday to pay $85 million to settle criminal charges in California that it failed to provide adequate usage directions for heart failure drug Natrecor.

Scios will plead guilty to violating the Food and Drug Administration Act and will be put on organizational probation for three years, according to the plea agreement.

"It is an appropriate penalty given the income, financial resources and earning capacity of Scios and its parent company, Johnson & Johnson; the limited burden such fine places...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

USA v. Scios, Inc.


Case Number

3:11-cr-00461

Court

California Northern

Nature of Suit

Date Filed

July 7, 2011

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.